| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
7,215 | 7,090 | 6,518 | 6,023 | 4,133 | 2,227 | 1,888 |
General and administrative | ||||||
4,520 | 3,979 | 3,324 | 2,422 | 2,189 | 1,090 | 1,122 |
Total operating expenses | ||||||
11,735 | 11,069 | 9,842 | 8,445 | 6,322 | 3,317 | 3,010 |
Loss from operations | ||||||
-11,735 | -11,069 | -9,842 | -8,445 | -6,322 | -3,317 | -3,010 |
Other income: | ||||||
Interest income | ||||||
674 | 906 | 1,236 | 629 | 580 | - | - |
Other income, net | ||||||
22 | - | 2 | -3 | - | - | - |
Total other income | ||||||
696 | 909 | 1,238 | 626 | 580 | - | - |
Net loss and comprehensive loss | ||||||
-11,039 | -10,160 | -8,604 | -7,819 | -5,742 | -3,317 | -3,010 |
Net loss per share attributable to common stockholders, basic and diluted | ||||||
-0.34 | 6.89 | -0.26 | -1.54 | -6.89 | -4.75 | -4.36 |
Weighted-average common shares outstanding, basic and diluted | ||||||
32,897 | 33,261 | 32,707 | 5,083 | 833 | 698 | 691 |